Your browser doesn't support javascript.
loading
Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China.
Zhang, Hangjie; Hua, Qianhui; Nani Xu, Nani; Zhang, Xinpei; Chen, Bo; Ma, Xijun; Hu, Jie; Chen, Zhongbing; Yu, Pengfei; Lei, Huijun; Wang, Shenyu; Ding, Linling; Fu, Jian; Liao, Yuting; Yang, Juan; Jiang, Jianmin; Lv, Huakun.
  • Zhang H; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Hua Q; School of Medicine, Ningbo University, Ningbo, China.
  • Nani Xu N; Xihu District Center for Disease Control and Prevention, Hangzhou, China.
  • Zhang X; Shangyu District Center for Disease Control and Prevention, Shaoxing, China.
  • Chen B; Kaihua District Center for Disease Control and Prevention, Quzhou, China.
  • Ma X; Yuecheng District Center for Disease Control and Prevention, Shaoxing, China.
  • Hu J; Department of Immunization Program, Jiaxing Center for Disease Control and Prevention, Jiaxing, China.
  • Chen Z; Longyou District Center for Disease Control and Prevention, Quzhou, China.
  • Yu P; Department of Immunization Program, Jiaxing Center for Disease Control and Prevention, Jiaxing, China.
  • Lei H; Longyou District Center for Disease Control and Prevention, Quzhou, China.
  • Wang S; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Ding L; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Fu J; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Liao Y; School of Public Health, Xiamen University, Xiamen, China.
  • Yang J; School of Public Health, Xiamen University, Xiamen, China.
  • Jiang J; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Lv H; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Elife ; 122023 03 16.
Article en En | MEDLINE | ID: mdl-36928099
Background: Although inactivated COVID-19 vaccines are proven to be safe and effective in the general population, the dynamic response and duration of antibodies after vaccination in the real world should be further assessed. Methods: We enrolled 1067 volunteers who had been vaccinated with one or two doses of CoronaVac in Zhejiang Province, China. Another 90 healthy adults without previous vaccinations were recruited and vaccinated with three doses of CoronaVac, 28 days and 6 months apart. Serum samples were collected from multiple timepoints and analyzed for specific IgM/IgG and neutralizing antibodies (NAbs) for immunogenicity evaluation. Antibody responses to the Delta and Omicron variants were measured by pseudovirus-based neutralization tests. Results: Our results revealed that binding antibody IgM peaked 14-28 days after one dose of CoronaVac, while IgG and NAbs peaked approximately 1 month after the second dose then declined slightly over time. Antibody responses had waned by month 6 after vaccination and became undetectable in the majority of individuals at 12 months. Levels of NAbs to live SARS-CoV-2 were correlated with anti-SARS-CoV-2 IgG and NAbs to pseudovirus, but not IgM. Homologous booster around 6 months after primary vaccination activated anamnestic immunity and raised NAbs 25.5-fold. The neutralized fraction subsequently rose to 36.0% for Delta (p=0.03) and 4.3% for Omicron (p=0.004), and the response rate for Omicron rose from 7.9% (7/89)-17.8% (16/90). Conclusions: Two doses of CoronaVac vaccine resulted in limited protection over a short duration. The inactivated vaccine booster can reverse the decrease of antibody levels to prime strain, but it does not elicit potent neutralization against Omicron; therefore, the optimization of booster procedures is vital. Funding: Key Research and Development Program of Zhejiang Province; Key Program of Health Commission of Zhejiang Province/ Science Foundation of National Health Commission; Major Program of Zhejiang Municipal Natural Science Foundation; Explorer Program of Zhejiang Municipal Natural Science Foundation.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article